- Humanigen HGEN -68% as trial for COVID-19 therapy fails .
- Atara Biotherapeutics ATRA -46% on interim analysis of phase 2 study for multiple sclerosis candidate.
- TherapeuticsMD TXMD -41% as merger agreement ends .
- Helius Medical Technologies ( HSDT ) -11% .
- Histogen ( HSTO ) -10% .
- SunLink Health Systems ( SSY ) -9% .
- Kaspien Holdings ( KSPN ) -8% .
- Greenwich LifeSciences ( GLSI ) -7% .
- Regional Health Properties ( RHE ) -7% .
- Unity Software U -7% on merger pact with ironSource .
- MSP Recovery ( MSPR ) -7% .
- Rhythm Pharmaceuticals ( RYTM ) -6% .
- Phunware ( PHUN ) -6% .
- Fastenal FAST -5% on Q2 earnings release .
- HTG Molecular Diagnostics ( HTGM ) -5% .
For further details see:
Fastenal, Unity Software, MSP Recovery among premarket losers' pack